235 related articles for article (PubMed ID: 33433787)
21. The disturbance of lipid metabolism is correlated with neuropsychiatric symptoms in patients with Parkinson's disease.
Dong MX; Wei YD; Hu L
Chem Phys Lipids; 2021 Sep; 239():105112. PubMed ID: 34216587
[TBL] [Abstract][Full Text] [Related]
22. PDD-5S: A useful screening tool for Parkinson's disease dementia.
Lee WJ; Wu SL; Li JY; Chen CC; Lin JJ; Peng GS; Lin TK; Wang SJ; Chen RS; Yang YH; Tsai CH; Hsu JL; Liao YC; Chen SP; Fuh JL
Parkinsonism Relat Disord; 2016 Apr; 25():85-90. PubMed ID: 26872691
[TBL] [Abstract][Full Text] [Related]
23. Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
Piggott MA; Ballard CG; Dickinson HO; McKeith IG; Perry RH; Perry EK
Int J Neuropsychopharmacol; 2007 Apr; 10(2):231-44. PubMed ID: 16448581
[TBL] [Abstract][Full Text] [Related]
24. Postmenopausal estrogen use and Parkinson's disease with and without dementia.
Marder K; Tang MX; Alfaro B; Mejia H; Cote L; Jacobs D; Stern Y; Sano M; Mayeux R
Neurology; 1998 Apr; 50(4):1141-3. PubMed ID: 9566410
[TBL] [Abstract][Full Text] [Related]
25. Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.
Jesse S; Lehnert S; Jahn O; Parnetti L; Soininen H; Herukka SK; Steinacker P; Tawfik S; Tumani H; von Arnim CA; Neumann M; Kretzschmar HA; Kulaksiz H; Lenter M; Wiltfang J; Ferger B; Hengerer B; Otto M
PLoS One; 2012; 7(11):e48783. PubMed ID: 23144969
[TBL] [Abstract][Full Text] [Related]
26. Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia.
Walter U; Dressler D; Wolters A; Wittstock M; Greim B; Benecke R
J Neurol; 2006 Apr; 253(4):448-54. PubMed ID: 16267638
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia.
Garcia-Esparcia P; Koneti A; Rodríguez-Oroz MC; Gago B; Del Rio JA; Ferrer I
Brain Pathol; 2018 Jan; 28(1):43-57. PubMed ID: 27984680
[TBL] [Abstract][Full Text] [Related]
28. Transcranial Sonographic Alterations of Substantia Nigra and Third Ventricle in Parkinson's Disease with or without Dementia.
Dong ZF; Wang CS; Zhang YC; Zhang Y; Sheng YJ; Hu H; Luo WF; Liu CF
Chin Med J (Engl); 2017 Oct; 130(19):2291-2295. PubMed ID: 28937033
[TBL] [Abstract][Full Text] [Related]
29. Clinical Correlates of Cerebral Amyloid Deposition in Parkinson's Disease Dementia: Evidence from a PET Study.
Palermo G; Tommasini L; Aghakhanyan G; Frosini D; Giuntini M; Tognoni G; Bonuccelli U; Volterrani D; Ceravolo R
J Alzheimers Dis; 2019; 70(2):597-609. PubMed ID: 31256138
[TBL] [Abstract][Full Text] [Related]
30. metabolic profiling of Parkinson's disease and mild cognitive impairment.
Burté F; Houghton D; Lowes H; Pyle A; Nesbitt S; Yarnall A; Yu-Wai-Man P; Burn DJ; Santibanez-Koref M; Hudson G
Mov Disord; 2017 Jun; 32(6):927-932. PubMed ID: 28394042
[TBL] [Abstract][Full Text] [Related]
31. Hyperhomocysteinemia in levodopa-treated patients with Parkinson's disease dementia.
Zoccolella S; dell'Aquila C; Abruzzese G; Antonini A; Bonuccelli U; Canesi M; Cristina S; Marchese R; Pacchetti C; Zagaglia R; Logroscino G; Defazio G; Lamberti P; Livrea P
Mov Disord; 2009 May; 24(7):1028-33. PubMed ID: 19353704
[TBL] [Abstract][Full Text] [Related]
32. Microglia, amyloid, and glucose metabolism in Parkinson's disease with and without dementia.
Edison P; Ahmed I; Fan Z; Hinz R; Gelosa G; Ray Chaudhuri K; Walker Z; Turkheimer FE; Brooks DJ
Neuropsychopharmacology; 2013 May; 38(6):938-49. PubMed ID: 23303049
[TBL] [Abstract][Full Text] [Related]
33. Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency.
Gatt AP; Duncan OF; Attems J; Francis PT; Ballard CG; Bateman JM
Mov Disord; 2016 Mar; 31(3):352-9. PubMed ID: 26853899
[TBL] [Abstract][Full Text] [Related]
34. Decreased Serum Lipid Levels and Ratios Correlate with Low Prevalence of Coronary Heart Disease in Patients with Parkinson's Disease.
Bao M; Hu R; Chen Y; Wang N; Xue H; He J; Jin J; Kong W; Ke G; Xue Q
Clin Lab; 2018 Sep; 64(9):1413-1419. PubMed ID: 30274018
[TBL] [Abstract][Full Text] [Related]
35. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
[TBL] [Abstract][Full Text] [Related]
36. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.
Llebaria G; Pagonabarraga J; Kulisevsky J; García-Sánchez C; Pascual-Sedano B; Gironell A; Martínez-Corral M
Mov Disord; 2008 Aug; 23(11):1546-50. PubMed ID: 18546326
[TBL] [Abstract][Full Text] [Related]
37. Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease.
Compta Y; Valente T; Saura J; Segura B; Iranzo Á; Serradell M; Junqué C; Tolosa E; Valldeoriola F; Muñoz E; Santamaria J; Cámara A; Fernández M; Fortea J; Buongiorno M; Molinuevo JL; Bargalló N; Martí MJ
J Neurol; 2015 Feb; 262(2):294-306. PubMed ID: 25380583
[TBL] [Abstract][Full Text] [Related]
38. A metabolomic signature of treated and drug-naïve patients with Parkinson's disease: a pilot study.
Troisi J; Landolfi A; Vitale C; Longo K; Cozzolino A; Squillante M; Savanelli MC; Barone P; Amboni M
Metabolomics; 2019 Jun; 15(6):90. PubMed ID: 31183578
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease.
Compta Y; Martí MJ; Ibarretxe-Bilbao N; Junqué C; Valldeoriola F; Muñoz E; Ezquerra M; Ríos J; Tolosa E
Mov Disord; 2009 Nov; 24(15):2203-10. PubMed ID: 19795497
[TBL] [Abstract][Full Text] [Related]
40. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
